These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34082125)
1. Effectiveness of lanadelumab in patients with hereditary angioedema with normal C1 inhibitor and FXII mutation. Bouillet L; Bocquet A; Belbezier A; Boccon-Gibod I Ann Allergy Asthma Immunol; 2021 Sep; 127(3):391-392. PubMed ID: 34082125 [No Abstract] [Full Text] [Related]
2. Successful perinatal management of hereditary angioedema with normal C1 esterase inhibitor and factor XII mutation using C1 esterase inhibitor therapy. Gibbons KR; Abraham T; Sandhu M; Peppers BP; Girzhel JF; Hostoffer RW Ann Allergy Asthma Immunol; 2017 Dec; 119(6):558-559. PubMed ID: 29017903 [No Abstract] [Full Text] [Related]
3. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency. Suffritti C; Sartorio S; Berra S; Janu VP; Caccia S; Zanichelli A J Allergy Clin Immunol Pract; 2023 Mar; 11(3):963-965.e1. PubMed ID: 36379410 [No Abstract] [Full Text] [Related]
5. Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations. Bork K; Wulff K; Witzke G; Hardt J Allergy; 2015 Aug; 70(8):1004-12. PubMed ID: 25952149 [TBL] [Abstract][Full Text] [Related]
6. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema. Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546 [TBL] [Abstract][Full Text] [Related]
7. Lanadelumab: First Global Approval. Syed YY Drugs; 2018 Oct; 78(15):1633-1637. PubMed ID: 30267321 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency. Belbézier A; Boccon-Gibod I; Bouillet L J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2490-2491. PubMed ID: 33556593 [No Abstract] [Full Text] [Related]
9. Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema. Schlueter M; Nestler-Parr S J Comp Eff Res; 2024 May; 13(5):e230165. PubMed ID: 38545965 [No Abstract] [Full Text] [Related]
10. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment. Magerl M; Germenis AE; Maas C; Maurer M Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110 [TBL] [Abstract][Full Text] [Related]
11. Hereditary angioedema with normal c1 inhibition. Bork K Curr Allergy Asthma Rep; 2009 Jul; 9(4):280-5. PubMed ID: 19656474 [TBL] [Abstract][Full Text] [Related]
12. Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families. Veronez CL; Moreno AS; Constantino-Silva RN; Maia LSM; Ferriani MPL; Castro FFM; Valle SR; Nakamura VK; Cagini N; Gonçalves RF; Mansour E; Serpa FS; Coelho Dias GA; Piccirillo MA; Toledo E; de Souza Bernardes M; Cichon S; Stieber C; Arruda LK; Pesquero JB; Grumach AS J Allergy Clin Immunol Pract; 2018; 6(4):1209-1216.e8. PubMed ID: 29128335 [TBL] [Abstract][Full Text] [Related]
13. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence. Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692 [TBL] [Abstract][Full Text] [Related]
14. Lanadelumab for the prevention of hereditary angioedema attacks: A real-world UK audit. Dorr AD; Chopra C; Coulter TI; Dempster J; Dziadzio M; El-Shanawany T; Garcez T; Gompels M; Herriot R; Jain R; Levi M; Lorenzo L; Makki I; Mapazire E; Murng SHK; Noorani S; Savic S; Steele CL; Symons C; Tarzi M; Yong PFK; Kiani-Alikhan S Allergy; 2023 May; 78(5):1369-1371. PubMed ID: 36510404 [No Abstract] [Full Text] [Related]
15. Subcutaneous plasma-derived C1 inhibitor for long-term prophylaxis during pregnancy and breast-feeding in a patient with factor XII hereditary angioedema. Herraez L; Álvarez Sala P; Mielgo R J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2587-2588. PubMed ID: 37121510 [No Abstract] [Full Text] [Related]
16. Hereditary angioedema with normal C1 inhibitor. Bork K Immunol Allergy Clin North Am; 2013 Nov; 33(4):457-70. PubMed ID: 24176211 [TBL] [Abstract][Full Text] [Related]